Vitamin D Nuclear Receptor Ligand-Binding Domain Crystal Structures

Vitamin D

Volumn 1, Issue , 2005, Pages 279-289

  Rochel, Natacha ^a   Moras, Dino ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878073423     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012252687-9/50018-8     Document Type: Chapter

References (48)

1. Moras D, Gronemeyer H The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol 1998, 10:384-391.
2. Chambon P A decade of molecular biology of retinoic acid receptors. FASEB J 1996, 10:940-954.
3. McKenna NJ, Lanz RB, O'Malley BW Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 1999, 20:321-344.
4. Glass CK, Rosenfeld MG The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 2000, 14:121-141.
5. Freedman LP Increasing the complexity of coactivation in nuclear receptor signaling. Cell 1999, 97:5-8.
6. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 1995, 375:377-382.
7. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D Crystal structure of the RAR-gamma ligand-binding domain bound to all- trans retinoic acid. Nature 1995, 378:681-689.
8. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ A structural role for hormone in the thyroid hormone receptor. Nature 1995, 378:690-697.
9. Billas IM, Iwema T, Garnier JM, Mitschler A, Rochel N, Moras D Nature 2003, 426:91-96.
10. Svensson S, Ostberg T, Jacobsson M, Norstrom C, Stefansson K, Hallen D, Johansson IC, Zachrisson K, Ogg D, Jendeberg L EMBO J 2003, 22:4625-4633.
11. Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struc Biol 1996, 3:87-94.
12. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev 1998, 12:3343-3356.
13. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 1998, 395:137-143.
14. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998, 95:927-937.
15. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988, 85:3294-3298.
16. Burmester JK, Maeda N, DeLuca HF Isolation and expression of rat 1,25-dihydroxyvitamin D3 receptor cDNA. Proc Natl Acad Sci USA 1988, 85:9499-9502.
17. Kamei Y, Kawada T, Fukuwatari T, Ono T, Kato S, Sugimoto E Cloning and sequencing of the gene encoding the mouse vitamin D receptor. Gene 1995, 152:281-282.
18. Lu Z, Hanson K, DeLuca HF Cloning and origin of the two forms of chicken vitamin D receptor. Arch Biochem Biophys 1997, 339:99-106.
19. Li YC, Bergwitz C, Juppner H, Demay MB Cloning and characterization of the vitamin D receptor from Xenopus laevis. Endocrinology 1997, 138:2347-2353.
20. Suzuki T, Suzuki N, Srivastava AS, Kurokawa T Identification of cDNAs encoding two subtypes of vitamin D receptor in flounder, Paralichthys olivaceus. Biochem Biophys Res Commun 2000, 270:40-45.
21. Whitfield GK, Dang HT, Schluter SF, Bernstein RM, Bunag T, Manzon LA, Hsieh G, Dominguez CE, Youson JH, Haussler MR, Marchalonis JJ Cloning of a functional vitamin D receptor from the lamprey ( Petromyzon marinus), an ancient vertebrate lacking a calcified skeleton and teeth. Endocrinology 2003, 144:2704-2716.
22. Malloy PJ, Pike JW, Feldman D The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocrinol Rev 1999, 20:156-188.
23. Jurutka PW, Hsieh JC, Nakajima S, Haussler CA, Whitfield GK, Haussler MR Human vitamin D receptor phosphorylation by casein kinase II at Ser-208 potentiates transcriptional activation. Proc Natl Acad Sci USA 1996, 93:3519-3524.
24. Vaisanen S, Juntunen K, Itkonen A, Vihko P, Maenpaa PH Conformational studies of human vitamin-D receptor by antipeptide antibodies, partial proteolytic digestion and ligand binding. Eur J Biochem 1997, 248:156-162.
25. Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 2000, 5:173-179.
26. Rochel N, Tocchini-Valentini G, Egea PF, Juntunen K, Garnier JM, Vihko P, Moras D Functional and structural characterization of the insertion region in the ligand-binding domain of the vitamin D nuclear receptor. Eur J Biochem 2001, 268:971-979.
27. Juntunen K, Rochel N, Moras D, Vihko P Large-scale expression and purification of the human vitamin D receptor and its ligand-binding domain for structural studies. Biochem J 1999, 344:297-303.
28. Tocchini-Valentini G, Rochel N, Wurtz JM, Mitschler A, Moras D Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc Natl Acad Sci USA 2001, 98:5491-5496.
29. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389:753-758.
30. 3 indicates that the 6-s- cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s- cis- nor 6-s- trans-locked analogs are preferred for genomic biological responses. Mol Endocrinol 1997, 11:1518-1531.
31. 3. Bioorg Med Chem Lett 1998, 8:2145-2148.
32. Vaisanen S, Ryhanen S, Saarela JT, Perakyla M, Andersin T, Maenpaa PH Structurally and functionally important amino acids of the agonistic conformation of the human vitamin D receptor. Mol Pharmacol 2002, 62:788-794.
33. Choi M, Yamamoto K, Itoh T, Makishima M, Mangelsdorf DJ, Moras D, DeLuca HF, Yamada S Interaction between vitamin D receptor and vitamin D ligands. Two-dimensional alanine scanning mutational analysis. Chem Biol 2003, 10:261-270.
34. Ciesielski F, Rochel N, Mitschler A, Kouzmenko A, Moras D J Steroid Biochem Mol Biol 2004, 89-90:55-59.
35. Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA, Redinbo MR The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 2001, 292:2329-2333.
36. Watkins RE, Maglich JM, Moore LB, Wisely GB, Noble SM, Davis-Searles PR, Lambert MH, Kliewer SA, Redinbo MR 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry 2003, 42:1430-1438.
37. 3 analogues: A novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 1991, 42:1569-1575.
38. 3 are associated with enhanced activation of the vitamin D receptor. J Biol Chem 1995, 270:10551-10558.
39. 3 analognes and their 20-epi homologues with the vitamin D receptor. J Biol Chem 1997, 272:3336-3345.
40. 3 receptor. J Biol Chem 1999, 274:16838-16845.
41. Bouillon R, Okamura WH, Norman AW Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995, 16:200-257.
42. Dilworth FJ, Williams GR, Kissmeyer AM, Nielsen JL, Binderup E, Calverley MJ, Makin HL, Jones G The vitamin D analog, KH1060, is rapidly degraded both in vivo and in vitro via several pathways: principal metabolites generated retain significant biological activity. Endocrinology 1997, 138:5485-5496.
43. Shankar VN, Dilworth FJ, Makin HL, Schroeder NJ, Trafford DJ, Kissmeyer AM, Calverley MJ, Binderup E, Jones G Metabolism of the vitamin D analog EB1089 by cultured human cells: redirection of hydroxylation site to distal carbons of the side chain. Biochem Pharmacol 1997, 53:783-793.
44. 3 with two side chains: interaction with its nuclear receptor and cellular actions. J Med Chem 2000, 43:2719-2730.
45. 3 analogues with two side chains. J Cell Biochem 2001, 81:179-190.
46. Carlberg C Molecular basis of the selective activity of vitamin D analogues. J Cell Biochem 2003, 88:274-281.
47. Väisänen S, Peräkylä M, Kärkkäinen JI, Uskokovic R, Carlberg C Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor. Mol Pharmacol 2003, 63:1230-1237.
48. Egea PF, Mitschler A, Rochel N, Ruff M, Chambon P, Moras D Crystla structure of the human RXRα ligand-binding domain bound to its natural ligand: 9- cis retinoic acid. EMBO J 2000, 19:2592-2601.